Examples of 'in patients with severe hepatic' in a sentence
Meaning of "in patients with severe hepatic"
In patients with severe hepatic refers to individuals who have severe liver-related issues or conditions
How to use "in patients with severe hepatic" in a sentence
Basic
Advanced
in patients with severe hepatic
There are no data in patients with severe hepatic impairment.
In patients with severe hepatic impairment.
No data are available in patients with severe hepatic impairment.
In patients with severe hepatic impairment, a starting dose of 5 mg is recommended.
There is no experience in patients with severe hepatic impairment.
In patients with severe hepatic impairment, the data available are insufficient to.
Ziagen is contraindicated in patients with severe hepatic impairment.
Use in patients with severe hepatic impairment is not recommended.
Rasagiline is contraindicated in patients with severe hepatic impairment.
Safety in patients with severe hepatic impairment has not been established.
Rasitrio is contraindicated in patients with severe hepatic impairment.
In patients with severe hepatic impairment, the dose should be halved.
Rasagiline is contraindicated in patients with severe hepatic insufficiency.
In patients with severe hepatic insufficiency the use of buprenorphine / naloxone is contraindicated.
Sixmo is contraindicated in patients with severe hepatic impairment.
See also
In patients with severe hepatic impairment, the data available are insufficient to establish recommendations.
Empagliflozin exposure is increased in patients with severe hepatic impairment.
In patients with severe hepatic impairment, the use of this medication is not recommended.
Ifirmacombi is not indicated in patients with severe hepatic impairment.
In patients with severe hepatic impairment, the creatinine clearance may underestimate the renal insufficiency.
Efavirenz is contraindicated in patients with severe hepatic impairment see.
In patients with severe hepatic impairment, the use of Duodart is contraindicated.
There is a lack of data in patients with severe hepatic impairment.
In patients with severe hepatic impairment, fondaparinux should be used with care see section 4.4.
Tolucombi is not indicated in patients with severe hepatic impairment.
In patients with severe hepatic impairment, doxorubicin should not be administered ( see Contraindications ).
There is no data available in patients with severe hepatic impairment.
Use in patients with severe hepatic impairment see section 4.2.
No studies have been conducted in patients with severe hepatic impairment.
In patients with severe hepatic impairment, the use of buprenorphine is contraindicated ( see section 4.3 ).
Kinzalkomb is not indicated in patients with severe hepatic impairment.
In patients with severe hepatic insufficiency the use of buprenorphine / naloxone is contraindicated ( see section 4.3 ).
Karvezide is not indicated in patients with severe hepatic impairment.
There are no data regarding the administration of aflibercept in patients with severe hepatic impairment.
The use of mitotane in patients with severe hepatic impairment is not recommended.
Agenerase in combination with ritonavir is contraindicated in patients with severe hepatic impairment.
The use of pilocarpine in patients with severe hepatic insufficiency is not recommended.
The pharmacokinetics of cabozantinib was not evaluated in patients with severe hepatic impairment.
It Should not Be used in patients with severe hepatic impairment or sensitivity to this drug.
The pharmacokinetics of micafungin has not been studied in patients with severe hepatic insufficiency.
There are no data in patients with severe hepatic impairment classified as Child Pugh C.
There is no therapeutic experience with losartan in patients with severe hepatic impairment.
Therefore, use in patients with severe hepatic impairment is not recommended.
Posaconazole should be used with caution in patients with severe hepatic impairment.
E factors in patients with severe hepatic impairment see section 4.2.
Trastuzumab emtansine was not studied in patients with severe hepatic impairment.
Rasagiline use in patients with severe hepatic impairment is contraindicated see section 4.3.
Use of tolperisone is not recommended in patients with severe hepatic impairment.
Xadago use in patients with severe hepatic impairment is contraindicated see section 4.3.
Paliperidone has not been studied in patients with severe hepatic impairment.
You'll also be interested in:
Examples of using Hepatic
Show more
Progressive renal or hepatic end organ dysfunction
Hepatic toxicity has been associated with acetaminophen
Monitoring of the hepatic function is also recommended
Examples of using Severe
Show more
This place has a severe tonal problem
Severe thermal burns can occur on contact
There are mild and severe cases of frostbite
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
